Arcellx, Inc. (ACLX)
114.77
+0.44
(+0.38%)
USD |
NASDAQ |
Mar 20, 16:00
114.88
+0.11
(+0.10%)
After-Hours: 20:00
Arcellx Research and Development Expense (Quarterly) : 34.10M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.565B |
| Eli Lilly & Co. | 3.802B |
| Johnson & Johnson | 4.268B |
| Merck & Co., Inc. | 2.499B |
| BioMarin Pharmaceutical, Inc. | 192.41M |